Terms: = Bone cancer AND PTPN11, CFC, Q06124, 5781, ENSG00000179295, SHP2, MGC14433, SHP-2, BPTP3, PTP-1D, SH-PTP3, NS1, SH-PTP2, PTP2C AND Treatment
58 results:
1. [FLT3-ITD mutation-positive acute myeloid leukemia undergoing clonal transition with ptpn11 mutation at relapse].
Kurihara K; Sadato D; Najima Y; Hirama C; Haraguchi K; Kato K; Kondo K; Sadaga Y; Kato C; Sakai S; Kambara Y; Nabe Y; Teshima K; Asano K; Jinguji A; Shimabukuro M; Ouchi F; Inai K; Koi S; Shingai N; Toya T; Shimizu H; Kobayashi T; Oboki K; Harada H; Okuyama Y; Harada Y; Doki N
Rinsho Ketsueki; 2024; 65(2):63-68. PubMed ID: 38447999
[TBL] [Abstract] [Full Text] [Related]
2. IL-6/ERK signaling pathway participates in type I IFN-programmed, unconventional M2-like macrophage polarization.
Yang L; Guo P; Wang P; Wang W; Liu J
Sci Rep; 2023 Feb; 13(1):1827. PubMed ID: 36726024
[TBL] [Abstract] [Full Text] [Related]
3. Identification of key microRNAs as predictive biomarkers of Nilotinib response in chronic myeloid leukemia: a sub-analysis of the ENESTxtnd clinical trial.
Yen R; Grasedieck S; Wu A; Lin H; Su J; Rothe K; Nakamoto H; Forrest DL; Eaves CJ; Jiang X
Leukemia; 2022 Oct; 36(10):2443-2452. PubMed ID: 35999259
[TBL] [Abstract] [Full Text] [Related]
4. Imaging flow cytometry reveals a subset of TdT negative T-ALL blasts with very low forward scatter on conventional flow cytometry.
Rosenberg CA; Bill M; Maguire O; Petersen MA; Kjeldsen E; Hokland P; Ludvigsen M
Cytometry B Clin Cytom; 2022 Mar; 102(2):107-114. PubMed ID: 34648681
[TBL] [Abstract] [Full Text] [Related]
5. shp-2 deletion in CD4Cre expressing chondrocyte precursors leads to tumor development with wrist tropism.
McNamara JT; Huntington KE; Borys S; Jayasuriya CT; Brossay L
Sci Rep; 2021 Oct; 11(1):20006. PubMed ID: 34625577
[TBL] [Abstract] [Full Text] [Related]
6. The Prognostic Ability of RAS Pathway-Related Gene Mutations in Patients with Myeloid Neoplasms Treated with Hypomethylating Agents.
Park HS; Son BR; Shin KS; Byeon S; Kim HK; Yang Y; Jeong Y; Han HS; Lee KH; Kwon J
Acta Haematol; 2021; 144(6):649-659. PubMed ID: 34233332
[TBL] [Abstract] [Full Text] [Related]
7. Pediatric myelodysplastic syndrome with inflammatory manifestations: Diagnosis, genetics, treatment, and outcome.
Yanir AD; Krauss A; Stein J; Steinberg-Shemer O; Gilad O; Lotan SN; Dgany O; Krasnov T; Kodman Y; Feuerstein T; Mardoukh J; Fishman H; Geron I; Yacobovich J; Tamary H; Birger Y; Avrahami G; Izraeli S; Birenboim SB
Pediatr Blood Cancer; 2021 Oct; 68(10):e29138. PubMed ID: 34019335
[TBL] [Abstract] [Full Text] [Related]
8. Protein tyrosine phosphatases in multiple myeloma.
Abdollahi P; Köhn M; Børset M
Cancer Lett; 2021 Mar; 501():105-113. PubMed ID: 33290866
[TBL] [Abstract] [Full Text] [Related]
9. MERGE: A Multinational, Multicenter Observational Registry for Myeloproliferative Neoplasms in Asia, including Middle East, Turkey, and Algeria.
Yassin MA; Taher A; Mathews V; Hou HA; Shamsi T; Tuğlular TF; Xiao Z; Kim SJ; Depei W; Li J; Rippin G; Sadek I; Siddiqui A; Wong RS
Cancer Med; 2020 Jul; 9(13):4512-4526. PubMed ID: 32351024
[TBL] [Abstract] [Full Text] [Related]
10. Suppressed humoral immunity is associated with dengue nonstructural protein ns1-elicited anti-death receptor antibody fractions in mice.
Tsai CL; Sun DS; Su MT; Lien TS; Chen YH; Lin CY; Huang CH; King CC; Li CR; Chen TH; Chiu YH; Lu CC; Chang HH
Sci Rep; 2020 Apr; 10(1):6294. PubMed ID: 32286343
[TBL] [Abstract] [Full Text] [Related]
11. Rare myeloid sarcoma with KMT2A (MLL)-ELL fusion presenting as a vaginal wall mass.
Bao H; Gao J; Chen YH; Altman JK; Frankfurt O; Wilson AL; Sukhanova M; Chen Q; Lu X
Diagn Pathol; 2019 Mar; 14(1):26. PubMed ID: 30922345
[TBL] [Abstract] [Full Text] [Related]
12. Noonan syndrome-causing shp2 mutants impair ERK-dependent chondrocyte differentiation during endochondral bone growth.
Tajan M; Pernin-Grandjean J; Beton N; Gennero I; Capilla F; Neel BG; Araki T; Valet P; Tauber M; Salles JP; Yart A; Edouard T
Hum Mol Genet; 2018 Jul; 27(13):2276-2289. PubMed ID: 29659837
[TBL] [Abstract] [Full Text] [Related]
13. shp2 Regulates the Osteogenic Fate of Growth Plate Hypertrophic Chondrocytes.
Wang L; Huang J; Moore DC; Zuo C; Wu Q; Xie L; von der Mark K; Yuan X; Chen D; Warman ML; Ehrlich MG; Yang W
Sci Rep; 2017 Oct; 7(1):12699. PubMed ID: 28983104
[TBL] [Abstract] [Full Text] [Related]
14. shp2 is required for BCR-ABL1-induced hematologic neoplasia.
Gu S; Sayad A; Chan G; Yang W; Lu Z; Virtanen C; Van Etten RA; Neel BG
Leukemia; 2018 Jan; 32(1):203-213. PubMed ID: 28804122
[TBL] [Abstract] [Full Text] [Related]
15. Progression in patients with low- and intermediate-1-risk del(5q) myelodysplastic syndromes is predicted by a limited subset of mutations.
Scharenberg C; Giai V; Pellagatti A; Saft L; Dimitriou M; Jansson M; Jädersten M; Grandien A; Douagi I; Neuberg DS; LeBlanc K; Boultwood J; Karimi M; Jacobsen SE; Woll PS; Hellström-Lindberg E
Haematologica; 2017 Mar; 102(3):498-508. PubMed ID: 27884971
[TBL] [Abstract] [Full Text] [Related]
16. Cooperation of MLL/AF10(OM-LZ) with ptpn11 activating mutation induced monocytic leukemia with a shorter latency in a mouse bone marrow transplantation model.
Fu JF; Liang ST; Huang YJ; Liang KH; Yen TH; Liang DC; Shih LY
Int J Cancer; 2017 Mar; 140(5):1159-1172. PubMed ID: 27859216
[TBL] [Abstract] [Full Text] [Related]
17. Molecular Heterogeneity of Ewing Sarcoma as Detected by Ion Torrent Sequencing.
Zhang N; Liu H; Yue G; Zhang Y; You J; Wang H
PLoS One; 2016; 11(4):e0153546. PubMed ID: 27077911
[TBL] [Abstract] [Full Text] [Related]
18. Exostoses, enchondromatosis and metachondromatosis; diagnosis and management.
McFarlane J; Knight T; Sinha A; Cole T; Kiely N; Freeman R
Acta Orthop Belg; 2016 Mar; 82(1):102-5. PubMed ID: 26984661
[TBL] [Abstract] [Full Text] [Related]
19. Ex vivo virotherapy with myxoma virus does not impair hematopoietic stem and progenitor cells.
Villa NY; Bais S; Chan WM; Meacham AM; Wise E; Rahman MM; Moreb JS; Rosenau EH; Wingard JR; McFadden G; Cogle CR
Cytotherapy; 2016 Mar; 18(3):465-80. PubMed ID: 26857235
[TBL] [Abstract] [Full Text] [Related]
20. The genomic landscape of juvenile myelomonocytic leukemia.
Stieglitz E; Taylor-Weiner AN; Chang TY; Gelston LC; Wang YD; Mazor T; Esquivel E; Yu A; Seepo S; Olsen S; Rosenberg M; Archambeault SL; Abusin G; Beckman K; Brown PA; Briones M; Carcamo B; Cooper T; Dahl GV; Emanuel PD; Fluchel MN; Goyal RK; Hayashi RJ; Hitzler J; Hugge C; Liu YL; Messinger YH; Mahoney DH; Monteleone P; Nemecek ER; Roehrs PA; Schore RJ; Stine KC; Takemoto CM; Toretsky JA; Costello JF; Olshen AB; Stewart C; Li Y; Ma J; Gerbing RB; Alonzo TA; Getz G; Gruber T; Golub T; Stegmaier K; Loh ML
Nat Genet; 2015 Nov; 47(11):1326-1333. PubMed ID: 26457647
[TBL] [Abstract] [Full Text] [Related]
[Next]
